Lung Neoplasms × NET × 90 days × Clear all
NCT03093116 2026-04-03

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 5 FDA
NCT02012699 2026-01-22

iCaRe2

University of Nebraska

Recruiting
999,999 enrolled